Präzise Positionierung des unaufgebohrten Tibianagels (UTN) in kurzen distalen Fragmenten mit perkutanen Kirschner-Drähten

A. Biewener,S. Rammelt,R. Grass,H. Zwipp

DOI: https://doi.org/10.1007/s10039-002-0679-7

2003-03-01

Trauma und Berufskrankheit

Abstract:

What problem does this paper attempt to address?

Association Between the LINC00673 Rs11655237 C> T Polymorphisms with Cancer Risk in the Chinese Population: A Meta-Analysis

Hongyu Zhang,Baixiu Wu,Ka Liang,Liuhua Ke,Xingxuan Ma,Changliu Luo,Yong He

DOI: https://doi.org/10.1097/md.0000000000030353

IF: 1.6

2022-01-01

Medicine

Abstract:The present study aimed to conduct a meta-analysis of previously published studies in order to clarify the association of long noncoding RNA (lncRNAs) LINC00673 rs11655237 C> T polymorphism with cancer risk.Systematic review and meta-analysis.Electronic databases of PubMed, EMBASE, Web of Science, Cochrane Library, Chinese National Knowledge Infrastructure, and Wanfang Database were used to search relevant studies. Studies published up to October 20, 2019 were included. The included studies were assessed in the following genetic model: allelic model, homozygote model, Heterozygote model, dominant model, recessive model. Data syntheses were conducted using STATA 12.0.Participants with various types cancers were included.Odds ratio (ORs) and 95% confidence interval (CIs) were calculated to assess the risk of tumor.Seven articles including 7 case-control studies, 7423 cases and 11,049 controls were adopted for meta-analysis. Our result demonstrated that LINC00673 rs11655237 C> T was related to the cancer among all model including allelic model (T vs C: pooled OR = 1.24, 95% CI = 1.16-1.41, P < .001), homozygous model (TT vs CC: pooled OR=1.54, 95% CI = 1.36-1.76, P < .001), heterozygous model (CT vs CC: pooled OR=1.24, 95% CI = 1.16-1.32, P < .001), dominant model (CT + TT vs CC: pooled OR=1.28, 95% CI = 1.20-1.36, P < .001) and recessive model (TT vs CT+ CC: pooled OR=1.42, 95% CI = 1.25-1.61, P < .001). Subgroup analysis also demonstrated that polymorphisms at this site also increased the risk of neuroblastoma.Our results find that rs11655237 contributed to occurrence of cancer in all models in Chinese population.
Association Between the MTHFR A1298C Polymorphism and Risk of Cancer: Evidence from 265 Case–control Studies

Xin-Li Zhu,Zhi-Zhong Liu,Sen-Xiang Yan,Wei Wang,Rui-Xia Chang,Chun-Yan Zhang,Yan Guo

DOI: https://doi.org/10.1007/s00438-015-1082-y

IF: 2.98

2015-01-01

Molecular Genetics and Genomics

Abstract:Many molecular, epidemiological studies have been performed to explore the association between MTHFR A1298C polymorphism and cancer risk. However, the results were inconsistent or even contradictory. Hence, we performed a meta-analysis to investigate the association between cancer risk and MTHFR A1298C (81,040 cases and 114,975 controls from 265 studies) polymorphism. Overall, significant association was observed between MTHFR A1298C polymorphism and cancer risk when all eligible studies were pooled into the meta-analysis. In further stratified and sensitivity analyses, significantly increased cervical cancer (dominant model: OR 1.46, 95 % CI 1.13–1.90; AC vs. AA: OR 1.48, 95 % CI 1.13–1.92) and lymphoma (dominant model: OR 1.22, 95 % CI 1.04–1.44; recessive model: OR 1.66, 95 % CI 1.15–2.39; CC vs. AA: OR 1.75, 95 % CI 1.21–2.53) risk were observed in Asians, and significantly decreased colorectal cancer risk was found in Asians (recessive model: OR 0.75, 95 % CI 0.59–0.96; CC vs. AA: OR 0.77, 95 % CI 0.60–1.00). In summary, this meta-analysis suggests that MTHFR A1298C polymorphism is associated with increased cervical cancer and lymphoma risk in Asians, and MTHFR A1298C polymorphism is associated with decreased colorectal cancer risk in Asians. Moreover, this meta-analysis also points out the importance of new studies, such as oral cancer and chronic myeloid leukemia, because they had high heterogeneity in this meta-analysis (I 2 > 75 %).
Do tiny males grow up? Sperm competition and optimal resource allocation schedule of dwarf males of barnacles.

Sachi Yamaguchi,Y. Ozaki,Y. Yusa,Satoshi Takahashi

DOI: https://doi.org/10.1016/J.JTBI.2006.10.009

IF: 2.405

2007-03-21

Journal of Theoretical Biology

Abstract:
Effect of Polymorphism on IL1A to Cancer Susceptibility: Evidence Based on 34,016 Subjects

Haoran Xia,Yiding Chen,Jialin Meng,Chaozhao Liang

DOI: https://doi.org/10.1080/21691401.2019.1646750

2019-01-01

Abstract:IL-1α is closely related to the development and metastasis of cancer, and its polymorphisms have been reported affecting the susceptibility of malignancy tumors, yet the conclusions are controversial. Present an overall meta-analysis was performed to reach more general findings. Relevant literature was searched from Google Scholar, Web of Science, PubMed, EMBASE, CNKI database and Wanfang database, and the association among polymorphism and cancer risk was appraised by counting ORs and 95% CIs of overall and stratification analysis. The date from 15,586 cases and 18,430 controls in 40 publications were enrolled. There is significantly upregulated risk leads by rs3783553 in all genetic models, while the same tendency was found in all cancer types. The results also suggest a high risk of cancer susceptibility in patients carried rs1800587 polymorphism, of which draw out form allelic and homozygote models in overall studies, especially for cervical cancer. However, there are no significant results in analysis of rs17561. In a word, IL1A SNPs play an essential role in upregulating cancer susceptibility, and current analysis provides detail date for further study in the future.
Polymorphisms of a Novel Long Non-Coding RNA RP11-108K3.2 with Colorectal Cancer Susceptibility and Their Effects on Its Expression

Danjie Jiang,Mingjuan Jin,Ding Ye,Yingjun Li,Fangyuan Jing,Xiaocong Zhang,Qilong Li,Kun Chen

DOI: https://doi.org/10.1177/1724600819888512

2019-01-01

The International Journal of Biological Markers

Abstract:Background: RP11-108K3.2 was recently identified as a novel long non-coding RNA (lncRNA) transcript, and several single nucleotide polymorphisms (SNPs) have been identified in its coding region. This study aimed to explore the associations of tagSNPs in RP11-108K3.2 with the risk of colorectal cancer and their effects on its expression. Methods: A total of 821 colorectal cancer cases and 857 healthy controls were enrolled into this two-stage case-control study. Demographic characteristics and lifestyle information were collected by a validated questionnaire. Six tagSNPs were genotyped by using Sequenom MassARRAY platform. A total of 71 additional colorectal cancer cases were recruited, of which the genotypes of potential polymorphisms and the RP11-108K3.2 expression levels were determined. Results: In the discovery set, only the rs2470151 C/T polymorphism was found to have a promising association with the risk of colorectal cancer, and this polymorphism was further replicated in the validation set with a significantly decreased risk of colorectal cancer (adjusted odds ratio 0.73; 95% confidence interval 0.55, 0.97). Combined discovery set and validation set together, this negative association was found both in the heterozygote codominant model and the dominant model. Furthermore, colorectal cancer patients carrying rs2470151 CT/TT genotypes had a marginally lower RNA expression of RP11-108K3.2 than those carrying the CC genotype. Stratified analyses showed the association between rs2470151 and the risk of colorectal cancer were influenced by family history of cancer, smoking, alcohol consumption, and tea drinking. Conclusions: These findings suggest that RP11-108K3.2 rs2470151 had a significant association with the risk of colorectal cancer; this may help to predict the susceptibility of colorectal cancer in Chinese populations.
Distinct effects of rs895819 on risk of different cancers: an update meta-analysis.

Muxiong Chen,Wenpan Fang,Xinkai Wu,Suchen Bian,Guangdi Chen,Liqin Lu,Yu Weng

DOI: https://doi.org/10.18632/oncotarget.17454

2017-01-01

Oncotarget

Abstract:Previous studies have indicated an association between the genetic variant in pre-miR-27a rs895819 with A->G transition and cancer risk; however, the results remain inconsistent and somehow conflicting in different cancers. Therefore, to obtain a more reliable conclusion, we performed an update meta-analysis by searching PubMed database or other databases. Odds ratio (ORs) and 95% confidence interval (CIs) were calculated to evaluate cancer risk. A total of 34 case-control studies involving 15,388 cases and 18,704 controls were included. The results showed that rs895819 was associated with an increased cancer risk (GG vs. AA/AG: OR = 1.15, 95% CI = 1.02-1.29). Furthermore, stratification analyses revealed an association of rs895819 with increased cancer risk among Asians (GG vs. AA: OR = 1.17, 95% CI = 1.01-1.36; GG vs. AA/AG: OR = 1.18, 95% CI = 1.03-1.35), but not Caucasians. Interestingly, the [G] allele of rs895819 was significantly associated with decreased risk of breast cancer (G vs. A: OR = 0.91, 95% CI = 0.86-0.97). However, rs895819 was associated with increased risk of colorectal cancer (GG vs. AA: OR = 1.56, 95% CI = 1.31-1.85; GG vs. AA/AG: OR = 1.53, 95% CI = 1.30-1.79; G vs. A: OR = 1.19, 95% CI = 1.09-1.30) and lung cancer (GG vs. AA/AG: OR = 1.43, 95% CI = 1.00-2.04). In addition, no association was found between rs895819 and risk of gastric cancer or esophageal cancer. In conclusion, our findings suggest distinct effects of rs895819 on risk of different cancers, and future well-designed studies with large samples are required to further validate our results.
The HOTAIR , PRNCR1 and POLR2E polymorphisms are associated with cancer risk: a meta-analysis

Haiyan Chu,Qinbo Yuan,Qiuhan Hua,Xu Zhang,Meilin Wang,Na Tong,Wei Zhang,Jinfei Chen,Zhengdong Zhang

DOI: https://doi.org/10.18632/oncotarget.14920

2017-01-01

Oncotarget

Abstract:Long non-coding RNAs (LncRNAs) have been widely studied and aberrant expression of lncRNAs are involved in diverse cancers. Genetic variation in lncRNAs can influence the lncRNAs expression and function. At present, there are many studies to investigate the association between lncRNAs polymorphisms and cancer susceptibility. However, it has no systematic study to evaluate the association. We performed a metaanalysis to summarize the results of common lncRNAs (HOTAIR, PRNCR1, POLR2E and H19) polymorphisms on cancer risk, by using the random-effect model to obtain the odds ratio (ORs) and 95% confidence interval (95% CI). We also applied the meta-regression and publication bias analysis to seek the source of heterogeneity and evaluate the stability of results, respectively. The summary results indicated that HOTAIR rs920778 increased the cancer risk in recessive model (OR = 1.61, 95% CI = 1.08-2.41, P-heterogeneity< 0.001). For PRNCR1 (rs1016343, rs16901946) and POLR2E (rs3787016), we also found the significant association with incresed risk of cancer (all P< 0.05). However, we did not observe any significant association between H19 rs2107425 and cancer risk. Our meta-analysis results revealed that these four lncRNAs polymorphisms (HOTAIR rs920778, PRNCR1 rs1016343 and rs16901946, POLR2E rs3787016) can contribute to cancer risk. Further studies should confirm these findings.
-196 to -174Del, Rs4696480, Rs3804099 Polymorphisms of Toll-like Receptor 2 Gene Impact the Susceptibility of Cancers: Evidence from 37053 Subjects

Sheng-Lin Gao,Yi-Ding Chen,Chuang Yue,Jiasheng Chen,Li-Feng Zhang,Si-Min Wang,Li Zuo

DOI: https://doi.org/10.1042/bsr20191698

2019-01-01

Bioscience Reports

Abstract:Relationship between Toll-like receptor-2 (TLR2) and cancer risk has been illustrated in some studies, but their conclusions are inconsistent. Therefore, we designed this meta-analysis to explore a more accurate conclusion of whether TLR2 affects cancer risks. Articles were retrieved from various literature databases according to the criteria. We used STATA to calculate the odds ratio (OR) and 95% confidence interval (95% CI) to evaluate the relationship between certain polymorphism of TLR2 and cancer risk. Finally, 47 case-control studies met the criteria, comprising 15851 cases and 21182 controls. In the overall analysis, people are more likely to get cancer because of -196 to -174del in TLR2 in all five genetic models, B vs. A (OR = 1.468, 95% Cl = 1.129-1.91, P=0.005); BB vs. AA (OR = 1.716, 95% Cl = 1.178-2.5, P=0.005); BA vs. AA (OR = 1.408, 95% Cl = 1.092-1.816, P=0.008); BB+BA vs. AA (OR = 1.449, 95% Cl = 1.107-1.897, P=0.007); BB vs. BA+AA (OR = 1.517, 95% Cl = 1.092-2.107, P=0.013). Meanwhile, rs4696480 could significantly increase the risk of cancer in Caucasians, furthermore, rs3804099 significantly decreased cancer risk in overall analysis, but more subjects are necessary to confirm the results. All in all, this meta-analysis revealed that not only -196 to -174del increased the risk of among overall cancers, Caucasians are more likely to get cancer because of rs4696480, while rs3804099 polymorphism could reduce the risk of cancer in some genetic models. There is no direct evidence showing that rs5743708, rs3804100 and rs1898830 are related to cancer.
Association of LINC00673 rs11655237 polymorphism with cancer susceptibility: A meta-analysis based on 23,478 subjects

Na Li,Zhigang Cui,Dayang Huang,Min Gao,Sixuan Li,Mingyang Song,Ying Wang,Lianwei Tong,Zhihua Yin

DOI: https://doi.org/10.1016/j.ygeno.2020.07.015

IF: 4.31

2020-11-01

Genomics

Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>Some studies on the relationship between LINC00673 polymorphism and cancer susceptibility have been inconsistent. To perform a more comprehensively quantitative assessment of LINC00673 rs11655237 and risk of overall cancer, we operated this meta-analysis for the first time.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>A comprehensive search was conducted to obtain relevant literature up to November 20, 2019. Pooled odds ratios and 95% confidence intervals were utilized to assess rs11655237 and cancer susceptibility under five different genetic models.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Eventually, 11 case-control studies from 9 articles were included. We found that LINC00673 rs11655237 polymorphism increased the susceptibility to overall cancer under all genetic models in the overall population. By dividing ethnicity and cancer type into subgroups, we also obtained similar positive results in subgroups of Chinese population, pancreatic cancer, cervical cancer, neuroblastoma, hepatoblastoma and gastric cancer.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>Overall, this meta-analysis has demonstrated for the first time that LINC00673 rs11655237 could increase susceptibility to cancer.</p>

genetics & heredity,biotechnology & applied microbiology
Genetic Variant in Long Non-Coding RNA H19 Modulates Its Expression and Predicts Renal Cell Carcinoma Susceptibility and Mortality

Qiang Cao,Pengchao Li,Pu Cao,Jian Qian,Mulong Du,Li,Meilin Wang,Chao Qin,Pengfei Shao,Zhengdong Zhang,Qiang Lu,Zengjun Wang

DOI: https://doi.org/10.3389/fonc.2020.00785

IF: 4.7

2020-01-01

Frontiers in Oncology

Abstract:The long non-coding RNA (lncRNA) H19 has been demonstrated to play a crucial role in carcinogenesis, including renal cell carcinoma (RCC). However, the impact of genetic variations in H19 gene on RCC has not been investigated before. In the present study, we sought to evaluate whether genetic polymorphisms in H19 are related to the susceptibility and mortality of RCC. We genotyped four widely studied polymorphisms in H19 and assessed their relationship with susceptibility and prognosis of RCC in a case-control study compromising 1,027 cases and 1,094 controls. The functionality of the important polymorphism was further investigated by real-time polymerase chain reaction and luciferase reporter assay. We found that H19 rs2839698 was significantly associated with risk and prognosis of RCC. Compared with the H19 rs2839698 CC genotype, the variant genotypes (CT/TT) were significantly associated with increased risk of RCC (P = 0.023, OR = 1.21; 95% CI = 1.03-1.45). Besides, patients with variant genotypes (CT/TT) were more likely to develop large tumor (P = 0.003, OR = 1.47; 95% CI = 1.16-1.85) and advanced disease (P = 0.010, OR = 1.59; 95% CI = 1.12-2.26); and had a significantly unfavorable overall survival than those with the rs2839698 CC genotype (CT/TT vs. CC: Log-rank P = 0.026, HR = 2.25, 95%CI = 1.07-4.75). Furthermore, the CT/TT genotypes were associated with significantly increased expression of H19 in renal tissue. The luciferase reporter assays revealed the potential effect of rs2839698 variant on the binding of microRNAs to H19. Our results suggest that the H19 rs2839698 variant may be a genetic predictor of susceptibility and mortality of RCC. The risk effects and the functional impact of the variant on H19 still need further validation.
Association between long noncoding RNA rs944289 and rs7990916 polymorphisms and the risk of colorectal cancer in a Chinese population

Yan Wang,Zhiyuan Qiu,Guangyu Tian,Qianqian Zhu,Zhao Zhang,Rong Qin,Yong Peng,Weifeng Tang,Sheng Zhang,Yan Xi

DOI: https://doi.org/10.1038/s41598-022-06474-3

IF: 4.6

2022-02-15

Scientific Reports

Abstract:Abstract Long non-coding RNAs (LncRNAs) play vital roles in the tumorigenesis of many cancers. Single nucleotide polymorphisms (SNPs) of the lncRNA also play vital roles in tumorigenesis. We explored lncRNA rs944289 and rs7990916 polymorphisms and analyzed the relationship between these lncRNA polymorphisms with the colorectal cancer (CRC) risk in a Chinese population. We recruited 1003 CRC patients from the Affiliated People’s Hospital of Jiangsu University and the Fujian Medical University Union Hospital from October 2014 to August 2017. Genomic DNA was extracted using a DNA Kit from lymphocytes of peripheral blood and the genotyping was performed with a SNPscan method. We found that the rs944289 TT homozygote was associated with the decreased CRC risk in the overall population. LncRNA rs944289 TT decreased the CRC risk in the subgroup of female, male, age ≥ 61, without alcohol intake, smoking and BMI ≥ 24 by logistic regression. The subgroup analysis revealed that lncRNA rs7990916 was not associated with CRC risk except for age < 61. Logistic regression analysis revealed that lncRNA rs944289 TT homozygote was associated with the increased risk of rectum cancer (TT vs. CC + CT: adjusted OR = 1.29, 95% CI 1.10–1.66, P = 0.041) or colon cancer. In summary, we proved that lncRNA rs944289 might be significantly related to the decreased CRC risk in the Chinese Han populations and lncRNA rs7990916 was not associated with the CRC risk except for patients of age < 61. In the future, studies with larger samples should be conducted to validate our results.

multidisciplinary sciences
Associations of lncRNA <i>H19</i> Polymorphisms at MicroRNA Binding Sites with Glioma Susceptibility and Prognosis

Yujiao Deng,Linghui Zhou,Jia Yao,Yu Liu,Yi Zheng,Si Yang,Ying Wu,Na Li,Peng Xu,Lijuan Lyu,Dai Zhang,Jun Lyu,Zhijun Dai

DOI: https://doi.org/10.1016/j.omtn.2020.02.003

2020-01-01

Abstract:Glioma is the most common tumor of the central nervous system; variation in susceptibility and prognosis worldwide suggests that there are molecular and genetic differences among individuals. The H19 gene plays a dual role in carcinogenesis. In this study, associations between H19 polymorphisms and susceptibility as well as prognosis in glioma were evaluated. In total, 605 patients with glioma and 1,300 cancer-free subjects were enrolled in the study. Individuals with the rs3741219 A>G allele were less likely to develop glioma (relative risk [RR] = 0.54, 95% confidence interval [95% CI] = 0.45-0.63, p < 0.001), whereas rs217727 G>A and rs2839698 G>A genotypes were not associated with glioma risk. The associations between H19 polymorphisms and prognosis were assessed, including overall survival and progression-free survival. Three focused H19 polymorphisms did not show a significant effect on survival. Further analysis based on false-positive report probability validated these significant results. In the haplotype analysis, individuals with the G(rs217727)A(rs2839698)G(rs3741219) haplotype were less likely to develop glioma (odds ratio [OR] = 0.33, 95% CI = 0.23-0.46, p = 0.02). Overall, carriers of the rs3741219 AG or GG genotype of H19 have a decreased susceptibility to glioma, but polymorphisms in this gene are not related to prognosis.
Different Effects of Three Polymorphisms in MicroRNAs on Cancer Risk in Asian Population: Evidence from Published Literatures.

Yeqiong Xu,Ling Gu,Yuqin Pan,Rui Li,Tianyi Gao,Guoqi Song,Zhenlin Nie,Liping Chen,Shukui Wang,Bangshun He

DOI: https://doi.org/10.1371/journal.pone.0065123

IF: 3.7

2013-01-01

PLoS ONE

Abstract:MicroRNAs (miRNAs) are a class of small non-protein-coding RNAs, which have emerged as integrated and important post-transcriptional regulators of gene expression. It has been demonstrated that single nucleotide polymorphisms (SNPs) exist in protein-coding genes. Accumulated studies have evaluated the association of miRNA SNPs with cancer risk, especially in Asian population, which included a series of related studies. However, the results remain controversial for the different genetic backgrounds, living habits and environment exposed. To evaluate the relationship between SNPs in miRNAs and cancer risk, 21 studies focused on Asian population were enrolled for the pooled analysis for three polymorphisms rs2910164, rs11614913, rs3746444 in three miRNAs miR-146aG>C, miR-196a2C>T, miR-499A>G using odds ratios (ORs) with 95% confidence intervals (CIs). For rs2910164 polymorphism, C allele was observed association with decreased overall cancer risk. In addition, subgroup analysis revealed of rs2910164 C allele decreased hepatocellular carcinoma (HCC), cervical cancer and prostate cancer risk among Chinese population. For rs11614913 polymorphism, TT genotype was observed to be associated with decreased cancer risk, especially for cancer type of colorectal cancer (CRC), lung cancer and country of Korea, North India. Whereas, rs3746444 G allele was an increased cancer risk factor in Chinese population, especially for breast cancer. In conclusion, this meta-analysis indicated that rs2910164 C allele was associated with decreased cancer risk in Chinese population. However, the association varied from different cancer types. Furthermore, TT genotype of rs11614913 was associated with decreased cancer risk. While different cancer types and countries contributed to different effects. Whereas, rs3746444 G allele was a risk factor in Chinese population, and the association varied from different cancer types.
Lack of Association of Two Common Polymorphisms Rs2910164 and Rs11614913 with Susceptibility to Hepatocellular Carcinoma: a Meta-Analysis.

Zhongxia Wang,Yin Cao,Chunping Jiang,Guang Yang,Junhua Wu,Yitao Ding

DOI: https://doi.org/10.1371/journal.pone.0040039

IF: 3.7

2012-01-01

PLoS ONE

Abstract:BACKGROUND: Single nucleotide polymorphisms (SNPs) in microRNA-coding genes may participate in the process of carcinogenesis by altering the expression of tumor-related microRNAs. It has been suggested that two common SNPs rs2910164 in miR-146a and rs11614913 in miR-196a2 are associated with susceptibility to hepatocellular carcinoma (HCC). However, published results are inconsistent and inconclusive. In the present study, we performed a meta-analysis to systematically summarize the possible association between the two SNPs and the risk for HCC. METHODOLOGY/PRINCIPAL FINDINGS: We conducted a search of case-control studies on the associations of SNPs rs2910164 and/or rs11614913 with susceptibility to HCC in PubMed, EMBASE, ISI Web of Science, Cochrane Central Register of Controlled Trials, ScienceDirect, Wiley Online Library and Chinese National Knowledge Infrastructure databases. Data from eligible studies were extracted for meta-analysis. HCC risk associated with the two polymorphisms was estimated by pooled odds ratios (ORs) and 95% confidence intervals (95% CIs). 5 studies on rs2910164 and 4 studies on rs11614913 were included in our meta-analysis. Our results showed that neither allele frequency nor genotype distribution of the two polymorphisms was associated with risk for HCC in all genetic models. Similarly, subgroup analysis in Chinese population showed no association between the two SNPs and the susceptibility to HCC. CONCLUSIONS/SIGNIFICANCE: This meta-analysis suggests that two common SNPs rs2910164 and rs11614913 are not associated with the risk of HCC. Well-designed studies with larger sample size and more ethnic groups are required to further validate the results.
Association of Long Non-Coding RNA Polymorphisms with Gastric Cancer and Atrophic Gastritis

Vytenis Petkevicius,Greta Streleckiene,Kotryna Balciute,Alexander Link,Marcis Leja,Peter Malfertheiner,Jurgita Skieceviciene,Juozas Kupcinskas

DOI: https://doi.org/10.3390/genes11121505

2020-12-15

Abstract:Long non-coding RNAs (lncRNA) play an important role in the carcinogenesis of various tumours, including gastric cancer. This study aimed to assess the associations of lncRNA ANRIL, H19, MALAT1, MEG3, HOTAIR single-nucleotide polymorphisms (SNPs) with gastric cancer and atrophic gastritis. SNPs were analyzed in 613 gastric cancer patients, 118 patients with atrophic gastritis and 476 controls from three tertiary centers in Germany, Lithuania and Latvia. Genomic DNA was extracted from peripheral blood leukocytes. SNPs were genotyped by the real-time polymerase chain reaction. Results showed that carriers of MALAT1 rs3200401 CT genotype had the significantly higher odds of atrophic gastritis than those with CC genotype (OR-1.81; 95% CI 1.17-2.80, p = 0.0066). Higher odds of AG were found in a recessive model (CC vs. TT + CT) for ANRIL rs1333045 (OR-1.88; 95% CI 1.19-2.95, p = 0.0066). Carriers of ANRIL (rs17694493) GG genotype had higher odds of gastric cancer (OR-4.93; 95% CI 1.28-19.00) and atrophic gastritis (OR-5.11; 95% CI 1.10-23.80) compared with the CC genotype, and carriers of HOTAIR rs17840857 TG genotype had higher odds of atrophic gastritis (OR-1.61 95% CI 1.04-2.50) compared with the TT genotype; however, the ORs did not reach the adjusted significance threshold (p < 0.007). In summary, our data provide novel evidence for a possible link between lncRNA SNPs and premalignant condition of gastric cancer, suggesting the involvement of lncRNAs in gastric cancer development.
Structures of multidomain proteins adsorbed on hydrophobic interaction chromatography surfaces.

A. Gospodarek,Weitong Sun,J. O’Connell,E. Fernandez

DOI: https://doi.org/10.1016/j.chroma.2014.10.080

IF: 4.601

2014-12-05

Journal of Chromatography A

Abstract:
Influence of H19 polymorphisms on breast cancer: risk assessment and prognostic implications via LincRNA H19/miR-675 and downstream pathways

Ying Qi,Pengfei Zhao

DOI: https://doi.org/10.3389/fonc.2024.1436874

IF: 4.7

2024-08-29

Frontiers in Oncology

Abstract:Introduction Breast cancer, as the most prevalent malignancy among women globally, continues to exhibit rising incidence rates, particularly in China. The disease predominantly affects women aged 40 to 60 and is influenced by both genetic and environmental factors. This study focuses on the role of H19 gene polymorphisms, investigating their impact on breast cancer susceptibility, clinical outcomes, and response to treatment. Methods We engaged 581 breast cancer patients and 558 healthy controls, using TaqMan assays and DNA sequencing to determine genotypes at specific loci (rs11042167, rs2071095, rs2251375). We employed in situ hybridization and immunohistochemistry to measure the expression levels of LincRNA H19, miR-675, MRP3, HOXA1, and MMP16 in formalin-fixed, paraffin-embedded samples. Statistical analyses included chi-squared tests, logistic regression, and Kaplan-Meier survival curves to evaluate associations between genetic variations, gene expression, and clinical outcomes. Results Genotypes AG at rs11042167, GT at rs2071095, and AC at rs2251375 were significantly associated with increased risk of breast cancer. Notably, the AA genotype at rs11042167 and TT genotype at rs2071095 were linked to favorable prognosis. High expression levels of LincRNA H19, miR-675, MRP3, HOXA1, and MMP16 in cancer tissues correlated with advanced disease stages and poorer survival rates. Spearman correlation analysis revealed significant positive correlations between the expression of LincRNA H19 and miR-675 and specific genotypes, highlighting their potential regulatory roles in tumor progression. Discussion The study underscores the critical roles of LincRNA H19 and miR-675 as prognostic biomarkers in breast cancer, with their overexpression associated with disease progression and adverse outcomes. The H19/LincRNA H19/miR-675/MRP3-HOXA1-MMP16 axis offers promising targets for new therapeutic strategies, reflecting the complex interplay between genetic markers and breast cancer pathology. Conclusion The findings confirm that certain H19 SNPs are associated with heightened breast cancer risk and that the expression profiles of related genetic markers can significantly influence prognosis and treatment response. These biomarkers hold potential as targets for personalized therapy and early detection strategies in breast cancer, underscoring the importance of genetic research in understanding and managing this disease.

oncology
Association of Polymorphisms in Long Non-Coding RNA H19 with Coronary Artery Disease Risk in a Chinese Population.

Wei Gao,Meng Zhu,Hao Wang,Shan Zhao,Di Zhao,Yang,Ze-Mu Wang,Fang Wang,Zhi-Jian Yang,Xiang Lu,Lian-Sheng Wang

DOI: https://doi.org/10.1016/j.mrfmmm.2014.12.009

2015-01-01

Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis

Abstract:H19 is an imprinted gene transcribing a long non-coding RNA and is downregulated postnatally. Re-expression of H19 has been observed in patients with atherosclerosis. However, to date, no data has been published on the association of H19 polymorphisms with the risk of coronary artery disease (CAD). In this study, four polymorphisms, rs217727, rs2067051, rs2251375, rs4929984, were analyzed in 701 CAD patients and 873 age- and sex-matched control subjects. Polymorphisms were genotyped by TaqMan technology. Our data showed that the T variant of rs217727 was associated with an increased risk of CAD [additive model: odds ratio (OR)=2.05, 95%CI=1.35–3.12; dominant model: OR=1.46, 95% confidence interval (CI)=1.12–1.90; recessive model: OR=1.75, 95%CI=1.18–2.58], while A variant of rs2067051 was associated with a decreased risk of CAD (additive model: OR=0.66, 95%CI=0.45–0.96; recessive model: OR=0.71, 95%CI=0.50–0.99). Combined analysis showed that subjects carrying 3 or 4 risk alleles had a significantly increased risk of CAD, relative to those with 0–2 risk alleles (OR=1.61, 95%CI=1.20–2.15). Moreover, CAD patients with 3 or 4 risk alleles also had significantly higher Gensini scores than those with 0–2 risk alleles (P=0.001). Further haplotype-based analysis revealed that individuals with C-G-C-C, T-G-A-A, and T-A-A-A haplotypes indicated a higher prevalence of CAD (OR=1.88, 95%CI=1.03–3.43; OR=2.26, 95%CI=1.19–4.31; OR=2.66, 95%CI=1.34–5.25, respectively), compared to individuals with the most common C-G-A-C haplotype. In conclusion, our study demonstrates for the first time that common polymorphisms of H19 are associated with the risk and severity of CAD in a Chinese population. Future studies are needed to explore the underlying mechanisms of our findings.
Polymorphisms at Long Non-Coding RNAs and Prostate Cancer Risk in an Eastern Chinese Population

D-L Cao,C-Y Gu,Y Zhu,B Dai,H-L Zhang,G-H Shi,Y-J Shen,Y-P Zhu,C-G Ma,W-J Xiao,X-J Qin,G-W Lin,D-W Ye

DOI: https://doi.org/10.1038/pcan.2014.34

2014-01-01

Prostate Cancer and Prostatic Diseases

Abstract:Background: Controversial data on the association of single-nucleotide polymorphisms (SNPs, rs3787016G>A and rs10773338G>A) in long non-coding RNA (lncRNA) with prostate cancer risk were emerged. Considering possible genetic differences among populations, we conducted the present study to clarify these discrepancies and re-validate these results in an eastern Chinese population and thus provide clues for new therapeutic targets of prostate cancer. Methods: Genotypes of these two SNPs from 1015 ethnic Han Chinese patients with prostate cancer and 1032 cancer-free controls were determined by Taqman assays. Logistic regression models were used to calculate odds ratios (ORs) and 95% confidence intervals (CIs) for risk associations. Results: The association of rs3787016 A variant genotypes with a significantly higher prostate cancer risk were found (adjusted OR=1.418, 95% CI=1.090–1.844 for AA vs GG). Stratification analysis indicated that the risk of rs3787016 variant AG/AA genotypes was more evident in younger subjects, ever smoking, patients with Gleason score ⩾7(4+3) and highly aggressive status. All these risks were not present for rs10773338G>A. Conclusions: These findings suggested that lncRNA SNPs may contribute to prostate cancer risk in an eastern Chinese population. Larger and well-designed studies with different ethnic populations are warranted to validate our findings.
Association of rs 6505162 polymorphism in pre-miR-423 with cancer risk : a meta-analysis based on 5 , 891 cases and 7 , 622 controls

Wei Liu,Hongyan Zhang,Jun Ma,Yong Cheng,Wenguang Luo,Liting Qian,Hongbo Zhang,Jinjin Ran,Yuntian Li

2017-01-01

Abstract:MicroRNAs (miRNAs) function as negative gene regulators by inhibiting translation or cleaving target mRNAs, for which they are recognized as oncogenes or tumor suppressors. Single nucleotide polymorphisms (SNPs) in miRNAs are closely related with cancer risks. Several studies have evaluated the association of rs6505162 polymorphism in pre-miR-423 with cancer susceptibility. However, the results remain conflicting rather than conclusive. We conducted a meta-analysis of 9 studies that included 5,891 cases and 7,622 controls to identify this association. The meta-analysis showed that the pre-miR-423 rs6505162 polymorphism was not statistically associated with cancer risks in all genetic models. In the stratified analysis of cancer types, the variant AA (CC vs. AA: OR=0.651, 95% CI: 0.482-0.878, P=0.005) and CA/AA genotypes (CC vs. CA+AA: OR=0.644, 95% CI: 0.4460.931, P=0.019) were associated with a decreased risk of breast cancer compared with wild-type CC genotype. The same association in the allelic contrast (C vs. A: OR=0.808, 95% CI=0.699-0.934, P=0.004) was also observed. However, an increased risk of lung cancer was found in the co-dominant (CC vs. AA: OR=1.850, 95% CI: 1.0493.263, P=0.034) and recessive (CC vs. CA+AA: OR=1.364, 95% CI: 1.074-1.732, P=0.011) models. Furthermore, according to the stratified analysis of ethnicity, we found a highly significant association in the Caucasian population (CC vs. AA: OR=0.651, 95% CI: 0.482-0.878, P=0.005; CC vs. CA+AA: OR=0.644, 95% CI: 0.446-0.931, P=0.019; C vs. A: OR=0.808, 95% CI: 0.699-0.934, P=0.004), but no significant association in Asians and other ethnicities. In summary, this meta-analysis suggests a significant association between pre-miR-423 rs6505162 polymorphism and risk of breast cancer and lung cancer. To some extent, this polymorphism is closely related to cancer susceptibility in Caucasians. However, further large-scale case-control studies between this polymorphism and cancer risks are needed in the future.

Präzise Positionierung des unaufgebohrten Tibianagels (UTN) in kurzen distalen Fragmenten mit perkutanen Kirschner-Drähten

Association Between the LINC00673 Rs11655237 C&gt; T Polymorphisms with Cancer Risk in the Chinese Population: A Meta-Analysis

Association Between the MTHFR A1298C Polymorphism and Risk of Cancer: Evidence from 265 Case–control Studies

Do tiny males grow up? Sperm competition and optimal resource allocation schedule of dwarf males of barnacles.

Effect of Polymorphism on IL1A to Cancer Susceptibility: Evidence Based on 34,016 Subjects

Polymorphisms of a Novel Long Non-Coding RNA RP11-108K3.2 with Colorectal Cancer Susceptibility and Their Effects on Its Expression

Distinct effects of rs895819 on risk of different cancers: an update meta-analysis.

The HOTAIR , PRNCR1 and POLR2E polymorphisms are associated with cancer risk: a meta-analysis

-196 to -174Del, Rs4696480, Rs3804099 Polymorphisms of Toll-like Receptor 2 Gene Impact the Susceptibility of Cancers: Evidence from 37053 Subjects

Association of LINC00673 rs11655237 polymorphism with cancer susceptibility: A meta-analysis based on 23,478 subjects

Genetic Variant in Long Non-Coding RNA H19 Modulates Its Expression and Predicts Renal Cell Carcinoma Susceptibility and Mortality

Association between long noncoding RNA rs944289 and rs7990916 polymorphisms and the risk of colorectal cancer in a Chinese population

Associations of lncRNA <i>H19</i> Polymorphisms at MicroRNA Binding Sites with Glioma Susceptibility and Prognosis

Different Effects of Three Polymorphisms in MicroRNAs on Cancer Risk in Asian Population: Evidence from Published Literatures.

Lack of Association of Two Common Polymorphisms Rs2910164 and Rs11614913 with Susceptibility to Hepatocellular Carcinoma: a Meta-Analysis.

Association of Long Non-Coding RNA Polymorphisms with Gastric Cancer and Atrophic Gastritis

Structures of multidomain proteins adsorbed on hydrophobic interaction chromatography surfaces.

Influence of H19 polymorphisms on breast cancer: risk assessment and prognostic implications via LincRNA H19/miR-675 and downstream pathways

Association of Polymorphisms in Long Non-Coding RNA H19 with Coronary Artery Disease Risk in a Chinese Population.

Polymorphisms at Long Non-Coding RNAs and Prostate Cancer Risk in an Eastern Chinese Population

Association of rs 6505162 polymorphism in pre-miR-423 with cancer risk : a meta-analysis based on 5 , 891 cases and 7 , 622 controls

Association Between the LINC00673 Rs11655237 C> T Polymorphisms with Cancer Risk in the Chinese Population: A Meta-Analysis